Babak Rashidi

Dr. Babak Rashidi

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2024 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
MKMartin Klamrowski
Martin Klamrowski
RKRan Klein
Ran Klein
CMChristopher McCudden
Christopher McCudden
JGJames Robert Green
James Robert Green
BRBabak Rashidi
Babak Rashidi
GHGregory Hundemer
Gregory Hundemer
Key Points: Nearly half of all patients with CKD who progress to kidney failure initiate dialysis in an unplanned fashion, which is associated with poor outcomes. Machine learning models using routinely collected data can accurately predict 6- to 12-month kidney failure risk among the population with advanced CKD. These machine learning models retrospectively deliver advanced warning on a substantial proportion of unplanned dialysis events. Background: Approximately half of all patients with advanced CKD who progress to kidney failure initiate dialysis in an unplanned fashion, which is associated with high morbidity, mortality, and health care costs. A novel prediction model designed to identify patients with advanced CKD who are at high risk for developing kidney failure over short time frames (6–12 months) may help reduce the rates of unplanned dialysis and improve the quality of transitions from CKD to kidney failure. Methods: We performed a retrospective study using machine learning random forest algorithms incorporating routinely collected age and sex data along with time-varying trends in laboratory measurements to derive and validate 6- and 12-month kidney failure risk prediction models in the population with advanced CKD. The models were comprehensively characterized in three independent cohorts in Ontario, Canada—derived in a cohort of 1849 consecutive patients with advanced CKD (mean [SD] age 66 [15] years, eGFR 19 [7] ml/min per 1.73 m2) and validated in two external advanced CKD cohorts (n=1356; age 69 [14] years, eGFR 22 [7] ml/min per 1.73 m2). Results: Across all cohorts, 55% of patients experienced kidney failure, of whom 35% involved unplanned dialysis. The 6- and 12-month models demonstrated excellent discrimination with area under the receiver operating characteristic curve of 0.88 (95% confidence interval [CI], 0.87 to 0.89) and 0.87 (95% CI, 0.86 to 0.87) along with high probabilistic accuracy with the Brier scores of 0.10 (95% CI, 0.09 to 0.10) and 0.14 (95% CI, 0.13 to 0.14), respectively. The models were also well calibrated and delivered timely alerts on a significant number of patients who ultimately initiated dialysis in an unplanned fashion. Similar results were found upon external validation testing. Conclusions: These machine learning models using routinely collected patient data accurately predict near-future kidney failure risk among the population with advanced CKD and retrospectively deliver advanced warning on a substantial proportion of unplanned dialysis events. Optimal implementation strategies still need to be elucidated.

14 January 2022 in JMIR Research Protocols
Verified
Journal Article
Open access
HVHeather Anne Valk
Heather Anne Valk
CGCarlos Garcia-Ochoa
Carlos Garcia-Ochoa
JCJessica Fontaine Calder
Jessica Fontaine Calder
TMToba Miller
Toba Miller
BRBabak Rashidi
Babak Rashidi
RMReilly Musselman
Reilly Musselman
Background: Surgical site infections (SSIs) are the most common nosocomial infection and occur in 16.3% of patients undergoing colorectal surgery at our institution (The Ottawa Hospital), the majority of which are identified after discharge from hospital. Patients who suspect having an SSI generally present to the emergency department or surgery clinic. Both options for in-person interaction are costly to the health care system and patients. A mobile app, how2trak, has proven to be beneficial for patients with complex wounds at our institution by facilitating at-home monitoring and virtual consultations. Objective: This study aims to assess the feasibility of a randomized controlled trial to assess if how2trak can improve patients’ experience and increase detection of SSIs after colorectal surgery while reducing patients’ risk of COVID-19 exposure. Methods: In this single-center prospective feasibility trial, eligible patients undergoing colorectal surgery will be randomized to either standard care or how2trak postoperative monitoring of their incision, symptoms, and ostomy function. Patient self-assessments will be monitored by a nurse specialized in wound and ostomy care who will follow-up with patients with a suspected SSI. The primary outcome is feasibility as measured by enrollment, randomization, app usability, data extraction, and resource capacity. Results: This study was approved by our institution’s ethics board on February 26, 2021, and received support from The Ottawa Hospital Innovation and Care Funding on November 12, 2021. Recruitment started June 3, 2021, and 29 were patients enrolled as of September 2021. We expect to publish results in spring 2022. Conclusions: This study will determine the feasibility of using a mobile app to monitor patients’ wounds and detect SSIs after colorectal surgery. If feasible, we plan to assess if this mobile app facilitates SSI detection, enhances patient experience, and optimizes their care. Trial Registration: ClinicalTrials.gov NCT04869774; https://clinicaltrials.gov/ct2/show/NCT04869774 International Registered Report Identifier (IRRID): DERR1-10.2196/26717

1 October 2024 in BMJ Open
Verified
Journal Article
Open access
PDF file
EAElmira Amooei
Elmira Amooei
ABAmos Buh
Amos Buh
MKMartin Klamrowski
Martin Klamrowski
RSRisa Shorr
Risa Shorr
CMChristopher R McCudden
Christopher R McCudden
RKRan Klein
Ran Klein
Introduction Tacrolimus is an immunosuppressant commonly administered in transplant recipients. Given its narrow therapeutic range and susceptibility to various influencing variables, determining its optimal dosage is challenging. This systematic review seeks to identify effective analytical modelling techniques and methods for optimal tacrolimus dose prediction in solid transplant recipients. Methods and analysis This review will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) criteria. The study will review the literature published from database inception to 11 March 2024, that assesses predictive models of tacrolimus dosing through analytical modelling techniques. We will include both randomised and non-randomised, as well as cross-sectional, qualitative and before-and-after studies and will perform our searches in four main databases—Ovid/MEDLINE, PubMed/MEDLINE, Scopus, Embase and Web of Science, and search engines including Centers for Disease Control (CDC) and Google Scholar. Papers that are not published in English or French are excluded from this study. A narrative synthesis and meta-analysis will be done if the extracted information permits such analysis. Conference abstracts will be ignored unless they are recent (published within 2 years of the search date). Ethics and dissemination Ethics clearance is not required for this study as no primary data will be collected. The completed manuscript will be published, and the results of the study will be presented at conferences. Study registration International Prospective Register of Systematic Reviews (PROSPERO), CRD42024537212.

13 April 2026
Verified
Conference Paper
Open access
SRShri Harini Ramesh
Shri Harini Ramesh
FDForoozan Daneshzand
Foroozan Daneshzand
BRBabak Rashidi
Babak Rashidi
SRShriti Raj
Shriti Raj
HSHariharan Subramonyam
Hariharan Subramonyam
FRFateme Rajabiyazdi
Fateme Rajabiyazdi
As Artificial Intelligence (AI) conversational agents become widespread, people are increasingly using them for health information seeking. The use of off-the-shelf conversational agents for health information seeking could place high metacognitive demands (the need for extensive monitoring and control of one’s own thought process) on individuals, which could compromise their experience of seeking health information. However, currently, the specific demands that arise while using conversational agents for health information seeking, and the strategies people use to cope with those demands, remain unknown. To address these gaps, we conducted a think-aloud study with 15 participants as they sought health information using our off-the-shelf AI conversational agent. We identified the metacognitive demands such systems impose, the strategies people adopt in response, and propose considerations for designing beyond off-the-shelf interfaces to reduce these demands and support better user experiences and affordances in health information seeking.

31 March 2026 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
EAElmira Amooei
Elmira Amooei
NBNandini Biyani
Nandini Biyani
ABAmos Buh
Amos Buh
MKMartin Klamrowski
Martin Klamrowski
NANawaf M Alyahya
Nawaf M Alyahya
RKRan Klein
Ran Klein
Background: Tacrolimus dose optimization remains challenging due to its narrow therapeutic range and multiple influencing variables. This systematic review aimed to identify effective analytical modeling techniques for optimal tacrolimus dose prediction in solid organ transplant recipients. Methods: Two independent researchers conducted a comprehensive review of studies examining analytical models that optimize tacrolimus dosing, searching Medline, Scopus, Embase, Web of Science, and PubMed. Results: In total, 115 studies met the inclusion criteria. Pharmacokinetic models (74 studies), particularly two-compartment with Bayesian forecasting, were most frequently used. Machine learning (ML) approaches, with increasing adoption, have demonstrated promising improved predictive accuracy. Key predictive variables included CYP3A5 genotype, hematocrit levels, post-operative days, and weight; however, the significance of genomic features seemed to diminish progressively as therapeutic drug monitoring calibrates dosing in the months following post-transplant. Only ten studies performed external validation, and none incorporated adherence data or predicted long-term graft outcomes. Conclusions: Clinical deployment of predictive models for tacrolimus dosing remains uncommon. In research, pharmacokinetic models remain prevalent, with ML approaches showing early incremental promise. Limited external validation raises generalizability concerns. Future research should prioritize outcome-based evaluation metrics rather than error metrics.

6 June 2021 in JMIR Preprints
Verified
Preprint
Open access
HVHeather Anne Valk
Heather Anne Valk
CGCarlos Garcia-Ochoa
Carlos Garcia-Ochoa
JCJessica Fontaine Calder
Jessica Fontaine Calder
TMToba Miller
Toba Miller
BRBabak Rashidi
Babak Rashidi
RMReilly Musselman
Reilly Musselman
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Surgical site infections (SSIs) are the most common nosocomial infection and occur in 16.3% of patients undergoing colorectal surgery at our institution (The Ottawa Hospital), the majority of which are identified after discharge from hospital. Patients who suspect having an SSI generally present to the emergency department or surgery clinic. Both options for in-person interaction are costly to the health care system and patients. A mobile app, how2trak, has proven to be beneficial for patients with complex wounds at our institution by facilitating at-home monitoring and virtual consultations. Objective: This study aims to assess the feasibility of a randomized controlled trial to assess if how2trak can improve patients’ experience and increase detection of SSIs after colorectal surgery while reducing patients’ risk of COVID-19 exposure. Methods: In this single-center prospective feasibility trial, eligible patients undergoing colorectal surgery will be randomized to either standard care or how2trak postoperative monitoring of their incision, symptoms, and ostomy function. Patient self-assessments will be monitored by a nurse specialized in wound and ostomy care who will follow-up with patients with a suspected SSI. The primary outcome is feasibility as measured by enrollment, randomization, app usability, data extraction, and resource capacity. Results: This study was approved by our institution’s ethics board on February 26, 2021, and received support from The Ottawa Hospital Innovation and Care Funding on November 12, 2021. Recruitment started June 3, 2021, and 29 were patients enrolled as of September 2021. We expect to publish results in spring 2022. Conclusions: This study will determine the feasibility of using a mobile app to monitor patients’ wounds and detect SSIs after colorectal surgery. If feasible, we plan to assess if this mobile app facilitates SSI detection, enhances patient experience, and optimizes their care. Trial Registration: ClinicalTrials.gov NCT04869774; https://clinicaltrials.gov/ct2/show/NCT04869774